NASDAQ
Protagenic Therapeutics, Inc. (PTIX) has a fcf yield of -164.60% as of Friday, May 29, 2026. This represents a 2894.80% decrease compared to its 12-month average of -5.50%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.